OPTIMIZING THE DOSE OF PLERIXAFOR IN LOW BODY WEIGHT PATIENTS WITH NON-HODGKIN'S LYMPHOMA.L. Ma, B. Habtemariam,P. Dinndorf, M. S. Mercado, T. Lin,Y. WangCLINICAL PHARMACOLOGY & THERAPEUTICS(2016)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要